USE OF ANTI-CD3 IMMUNOTOXIN COMBINED WITH ANTI-PD-L1 SINGLE DOMAIN ANTIBODY IN TREATMENT OF CANCER

Provided is use of an anti-CD3 immunotoxin combined with an anti-PD-L1 single domain antibody in the preparation of medicaments for treatment of cancers. L'invention concerne l'utilisation d'une immunotoxine anti-CD3 combinée à un anticorps à domaine unique anti-PD-L1 dans la préparat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	YUAN, Taichang, TANG, Fangqiang, GONG, John, LIN, Yihui, DING, Chong
Format:	Patent
Sprache:	chi ; eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided is use of an anti-CD3 immunotoxin combined with an anti-PD-L1 single domain antibody in the preparation of medicaments for treatment of cancers. L'invention concerne l'utilisation d'une immunotoxine anti-CD3 combinée à un anticorps à domaine unique anti-PD-L1 dans la préparation de médicaments pour le traitement de cancers. 提供抗-CD3免疫毒素联合抗-PD-L1单域抗体在制备治疗癌症的药物中的应用。